Template:Oral hypoglycemics and insulin analogs: Difference between revisions
Appearance
Content deleted Content added
+Dulaglutide |
m sub--sup |
||
Line 75: | Line 75: | ||
* [[Albiglutide]]<sup>†</sup> |
* [[Albiglutide]]<sup>†</sup> |
||
* [[Lixisenatide]] |
* [[Lixisenatide]] |
||
* [[Dulaglutide]]< |
* [[Dulaglutide]]<>†</> |
||
| group4 = [[Dipeptidyl peptidase-4 inhibitor|DPP-4 inhibitor]]s |
| group4 = [[Dipeptidyl peptidase-4 inhibitor|DPP-4 inhibitor]]s |
Revision as of 12:59, 30 April 2014
This template's initial visibility currently defaults to autocollapse
, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state=
parameter may be used:
{{Oral hypoglycemics and insulin analogs|state=collapsed}}
will show the template collapsed, i.e. hidden apart from its title bar.{{Oral hypoglycemics and insulin analogs|state=expanded}}
will show the template expanded, i.e. fully visible.